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Peripherally induced Tregs (iTregs) are being recognized as a functional and physiologi-
cally relevant T-cell subset. Understanding the molecular basis of their development is a
necessary step before the therapeutic potential of iTreg manipulation can be exploited. In
this study, we report that the differentiation of primary human T cells to suppressor iTregs
involves the relocation of key proximal TCR signaling elements to the highly active
IL-2-Receptor (IL-2-R) pathway. In addition to the recruitment of lymphocyte-specific
protein tyrosine kinase (Lck) to the IL-2-R complex, we identified the dissociation of the
voltage-gated K1 channel Kv1.3 from the TCR pathway and its functional coupling to the
IL-2-R. The regulatory switch of Kv1.3 activity in iTregs may constitute an important
contributing factor in the signaling rewiring associated with the development of peripheral
human iTregs and sheds new light upon the reciprocal crosstalk between the TCR and the
IL-2-R pathways.
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Introduction
Recent evidence supports the major role of peripherally induced
regulatory T cells (iTregs) in controlling the immune response
during inflammatory processes and against infectious agents
[1–3]. The high degree of plasticity in the iTreg developmental
program represents an additional challenge to the inherent
difficulties associated with the study of human Tregs, such as
insufficient number of cells, heterogeneous cell population and
staggering differences between human and mouse models. These
intrinsic limitations have prevented a comprehensive under-
standing of the differential signaling events that govern the
development and function of Tregs. In the study presented here,
we have taken advantage of a cell culture system that
simultaneously generates functional populations of naı̈ve,
memory, effector T cells and iTregs from an original pool of
primary human CD41 T cells. With this unique platform, we
wanted to gain a better understanding of the signaling events that
contribute to the altered proximal TCR-mediated activation of
iTregs. A comparative analysis among T-cell subsets identified the
uncoupling of voltage-gated Shaker family K1-channel Kv1.3
activity from TCR engagement in iTregs. Kv1.3 has been
implicated in the activation, migration, adhesion and volume
regulation of human T cells [4]. Our findings demonstrate that, in
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iTregs, Kv1.3 and the reportedly functionally linked lymphocyte-
specific protein tyrosine kinase (Lck) relocate to and participate
in the signaling pathway triggered by the highly active IL-2-
Receptor (IL-2-R) complex. We propose that the physical and
functional redistribution of protein clusters, in addition to being
instrumental to the altered TCR pathway in iTregs, may represent
a common contributing mechanism to the signaling plasticity that
governs T-cell lineage differentiation.
Results and discussion
Altered TCR signaling in iTregs
The physiological relevance of Tregs in the control of the immune
response emphasizes the importance of understanding the
molecular mechanisms underlying their development and func-
tion. In addition to naturally occurring, thymus-derived CD41
CD25highFoxP31cells (nTregs), a microenvironment enriched
with IL-2 and TGF-b can induce peripheral CD41 cells to
differentiate into suppressor T cells in vivo and ex vivo [1, 2].
We have optimized culture conditions for CD41 CD25 primary
T cells to allow the induction and discrimination of iTregs, naı̈ve,
memory and effector T cells. Cells that differentiate to a Treg-like
phenotype also exhibit potent suppression of conventional CD41
T-cell proliferation (Supporting Information Fig. 1A). As
expected, iTregs generated in our conditions had already
acquired specific Treg signaling trademarks. Notably, iTregs
exhibited a low activation of AKT in response to TCR engage-
ment. In contrast, ERK activation was remarkably effective
(Fig. 1A), indicating that the blockage of the AKT pathway in
iTregs did not occur as a result of a general failure of the TCR
signaling machinery. Therefore, we propose that the differentiation
to iTregs involves the rewiring of the signaling network associated
with TCR-dependent events upstream of the AKT pathway.
Functional dissociation between Kv1.3 and TCR
activation in iTregs
Previously, we demonstrated that, in contrast to conventional
CD41 and CD81 T cells, the activation of the K1 channel Kv1.3
was refractory to TCR stimulation in human nTregs [5]. To
explore whether iTregs displayed the same functional trait along
with the acquisition of other regulatory/suppressor trademarks,
we analyzed and compared the response of Kv1.3 to TCR
engagement among different T-cell subsets. Using an automated,
high-throughput patch-clamp screening assay, we found a similar
profile of weak Kv1.3 response to TCR stimulation in induced and
natural Tregs (Fig. 2A). Based on the observation that the mRNA
and protein expression of Kv1.3 remained steady compared to
effector cells (Fig. 2B), these findings suggest that the functional
dissociation between TCR and Kv1.3 activity is likely due to the
remodeling of the TCR signaling network during iTreg differ-
entiation.
Regulation of Lck activity by IL-2-R pathway in iTregs
The association between the Src-family tyrosine kinase Lck and
Kv1.3 is necessary for the initiation of the TCR-mediated
signaling triggered during the formation of the immune synapse
[6–8] and has been reported in other, non-TCR-dependent, T-cell
responses as well [9–11]. Therefore, we explored whether a
differential Lck activation in iTregs may concur with the loss of
control of Kv1.3 activity by TCR. In our experimental setting of
comparative Western blot analysis depicted in Fig. 1A, iTregs
exhibited the highest levels of active Lck in mock-treated samples
under normal resting conditions (2 h on ice), as indicated by the
intense phosphorylation of Lck at Y394. In spite (or because) of
this high basal activity, iTregs displayed a reduced capacity to
increase Lck activation in response to TCR ligation. A phenotypic
attribute of iTregs is the high expression of CD25, the IL-2-Ra
subunit that associates with the IL-2-Rb (CD122) and the
common g (CD132) chains to form the high-affinity IL-2-R
complex. In conjunction with the requirement for a constant
supply of IL-2, the enhanced expressionn of the high-affinity
IL-2-R complex underscores the critical role that the IL-2/IL-2-R
pathway plays in iTreg development [12, 13]. In this context, the
fact that Lck exhibited a similarly enhanced activity in iTregs
when the TCR signaling machinery was not triggered suggests
that an alternative pathway might activate Lck. In order to assess
the potential involvement of the highly active IL-2-R, we
performed co-immunoprecipitation assays of Lck from effector
T cells and iTreg lysates. The results in Fig. 3A confirmed that the
physical association between Lck and the IL-2-Rb subunit
occurred only in iTregs. In addition, we generated evidence that
Lck is activated upon IL-2-R engagement in iTregs. Sorted iTregs
rested for additional period of time (6–7 h on ice) revealed the
activation of TCR-dependent downstream events (as depicted in
Fig. 3B by the phosphorylation of LAT), although the actual level
of activated Lck was essentially identical for TCR crosslinked and
mock-activated cells. Conversely, a marked increase of Y394-
phosphorylated Lck was detected in iTregs treated with IL-2 that
paralleled the IL-2-R-induced phosphorylation of STAT5. In
agreement with others [14, 15], these findings support the direct
involvement of Lck in the IL-2-R signal transduction pathway of
iTregs. Since we observed no differences in Lck expression
between conventional T cells and iTregs (Figs. 1B, 1C and 3A),
these results are consistent with the redistribution of Lck to the
IL-2-R cluster occurring during the development of iTregs.
Regulation of Kv1.3 function by IL-2-R pathway in iTregs
We next wanted to address the question of whether the
relocalization and clustering of Lck to the IL-2-R complex in
iTregs encompassed the regulatory switch of Kv1.3 activity. The
functional incidence of Kv1.3 spatial redistribution has been
already documented in T cells [6–11]. In order to examine
whether the TCR-dissociated Kv1.3 becomes functionally
linked to the highly active IL-2-R complex, we performed
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high-throughput patch clamp analysis with sorted iTregs incu-
bated with IL-2, IL-6 or IL-10. Figure 3C shows that, in contrast to
the weak response observed upon TCR ligation, iTregs in culture
with IL-2 sustain significantly larger Kv1.3 peak currents
compared with cells cultured with IL-6 or IL-10. These results
provide, to our knowledge, the first evidence of the functional
integration of Kv1.3 into the IL-2-R network in human T cells.
Moreover, the linkage of Kv1.3 to the highly Lck-activating IL-2-R
coincides with the functional uncoupling from TCR control. The
enzymatic activity of Lck is required to initiate the TCR signaling
cascade that regulates T-cell development, differentiation and
activation [16]. However, despite extensive investigation, the
precise mechanistic principles that orchestrate the earliest
signaling events induced by Lck are still elusive. Recent reports
propose that a pool of pre-activated-Lck gains access to the ITAM
sequences within the CD3/TCRz complex exposed by the
conformational changes upon TCR engagement [17, 18].
According to this model, rather than the activation of Lck, the
critical priming step in the initiation of the TCR pathway would
be the substrate accessibility (i.e. CD3 and TCRz cytoplasmic
tails) to the pool of available Lck. Haughn et al. [19]
demonstrated that a very active, high-affinity IL-2-R in T cells
might cause the functional uncoupling of the TCR signaling
machinery through diversion of the subcellular localization of Lck
to the IL-2-R multiprotein. Accordingly, the strong activation of
Lck by the IL-2-R pathway in iTregs may compromise the amount
of Lck available in CD3/TCR complexes and therefore alter the
TCR signaling cascade. In agreement with other reports [7–9],
our findings also suggest that Kv1.3 remains functionally linked
with the pool of Lck susceptible to lateral mobility. Interestingly,
the differentiation to iTregs occurs preferentially in cells that
undergo strong proliferative expansion (not shown), which
involves continuous TCR-mediated regulation of Kv1.3 function
and requires a strong activation of the AKT pathway. During the
transition to the differentiation stage and the acquisition of the
suppressor phenotype, the formation of new protein complexes
occurs concomitantly with the remodeling of functional signaling
paths that eventually dissociate AKT and Kv1.3 activities from the
TCR network. We provide evidence that uncoupling early TCR
signaling elements occurs, in addition to other potential
mechanisms [20], through the competitive crosstalk between
TCR and IL-2-R pathways in cells with high IL-2-dependent
activity. These findings support a dynamic model by which the
redistribution of common, key signaling components (Lck-Kv1.3)
may represent a rapid and efficient mechanism of adapting the
cell signaling machinery to a new environmental context. The
functional switch from antigen-dependent signaling in effector
cells to cytokine-dependent responsiveness in iTregs is consistent
with the physiological prevalence of the suppressor activity of
iTregs upon antigen clearance.
Figure 1. TCR-dependent signaling in iTregs. (A) Sorted CD41CD25 T cells, effector T cells and iTregs were rested for 2 h on ice and activated (1) or
not () by anti-CD3 crosslink for 3 min. Lysates of 5 105 cells were analyzed by Western blot to detect activated (phosphorylated) forms and total
protein expression of Lck/Fyn (anti-pY416-Src recognizes both pY394-Lck and pY417-Fyn), AKT, LAT and ERK. GAPDH expression demonstrated
equivalent loading. Protein band densities were quantified by densitometry. Ratio of phosphorylated:total protein was normalized to that of mock-
treated CD25 cells and depicted as mock-treated (empty bars) or CD3 crosslinked (black bars) cells. (B) Lysates from 5105 cells were analyzed by
Western blot to detect the pattern of expression of proteins involved in early events of TCR signaling. Protein band densities were quantified and
normalized to that of CD25 cells as indicated below each blot. (C) Transcription of the LCK gene was quantified from CD25 T cells, effector T cells,
and iTregs. FOXP3 (as a positive control) and GAPDH (housekeeping gene) were assessed as control. Briefly, total RNA was extracted from 5 to
7106 sorted cells. cDNA was obtained by reverse transcription and used as a template in a microarray analysis with the Affymetrix GeneChip
System (Human Genome U133 Plus 2.0 Array microchip). The results represent the comparative mean value of triplicates from three different
donors relative to CD25 samples; bars represent the experimental range of the triplicates. The results were validated with real-time PCR (not
shown).
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Concluding remarks
Collectively, these results: (i) provide a novel mechanistic link
between the remodeling of a signaling network and the
acquisition of suppressor iTreg phenotype with the selective
relocation of TCR-associated proximal components; (ii) support
the importance of the finely tuned TCR/IL-2-R crosstalk in the
control of T-cell fate decisions and (iii) underscore the
differential role that K1 channels may play in specific T-cell
subpopulations and/or their functional responses.
Materials and methods
Cell isolation, culture conditions and suppression assay are
detailed in Supporting Information.
Buffer compositions
In total, 100 mM K1-D-gluconic acid, 50 mM KCl, 3 mM MgCl2
and 5 mM EGTA pH 7.3 was used as intracellular recording
solution in the patch-clamping. Radio-Immuno-Precipitation
Assay (RIPA) buffer: 50 mM Tris-HCl, pH 7.4; 150 mM NaCl,
0.1% SDS, 0.5% Na-Deoxycholate and 1% Triton X-100.
Immunoprecipitation lysis buffer: 50 mM Tris-HCl, pH 7.4;
150 mM NaCl, 1% Nonidet P-40 and 0.5% n-dodecyl-b-D-malto-
side. Lysis buffers were supplemented with 1 mM PMSF and Halt
Protease inhibitor cocktail (Pierce).
T-cell activation and lysates
Cells were stimulated with anti-CD3 (0.5 mg/106 cells) cross-
linked with anti-mouse IgG (1.2 mg/106 cells) for 3 min at 371C or
incubated with IL-2 (5 ng/mL) for 6–7 h. Later, cells were lysed
for Western blotting or immunoprecipitation.
Figure 2. Kv1.3 in iTregs. (A) CD41CD25 T cells and nTregs isolated
from the same donors were cultured in iTreg medium (Supporting
information). After 6 days, CD41CD25 T cells, effector T cells, and
iTregs were sorted and maintained for 60 h in serum-free AIMV
medium with or without 0.15 mg/mL of soluble anti-CD3 antibody.
Kv1.3 current in sorted cells and nTregs was measured with high-
throughput patch-clamping screening. Experimental values represent
the combined distribution of Kv1.3 measurements on individual cells
isolated from three independent experiments. N 5 255 CD41CD25
cells; N 5 186 effector cells; N 5 88 nTregs; N 5 129 iTregs. The distribu-
tion of Kv1.3 values is depicted in box plots with whiskers representing
the 10th and 90th percentiles of experimental values; boxes are limited
by the 25th and the 75th percentiles; solid lines are the medians, and
dark squares represent the mean values. A two-sample Kolmogor-
ov–Smirnov test was used to compare paired distributions of Kv1.3
currents. (B) Sorted CD41CD25T cells, effector T cells, and iTregs were
analyzed by Western blot to compare the expression of Kv1.3. The
double-banded pattern depicted in effector and iTreg Kv1.3 blots may
likely correspond to different glycosylation forms of Kv1.3 [23].
Quantification of protein expression was normalized to the band
density of CD25 cells. GAPDH levels demonstrate equal protein
loading. Gene expression was determined as detailed in Fig. 1C.
Figure 3. Lck and Kv1.3 respond to IL-2 in iTregs. (A) Lysates from 107 effector T cells and iTregs were incubated with Lck antibody-loaded agarose
beads or Ig-isotype control (IgC). Cell extracts and immunoprecipitates were analyzed by SDS-PAGE and Western blots using CD122 (IL-2-Rb) and
Lck antibodies. Quantification of co-immunoprecipitates was determined by the relative ratio of IL-2-Rb bound to Lck and normalized at 1.0 in
effector cells. (B) Sorted iTregs were rested for 6–7 h on ice and mock-activated, anti-CD3 crosslinked or IL-2 treated. Lysates of 5105 cells were
subjected to immunoblotting using the indicated antibodies. LAT expression verified equal loading. Quantification of protein expression was
normalized on the basis of mock-treated iTregs for each individual blot. (C) Sorted iTregs were cultured for 60 h in AIMV with or without 5 ng/mL of
IL-2, IL-6 or IL-10. Depiction and measurement of Kv1.3 currents were performed as described in Fig. 2. Profiles of Kv1.3 currents represent the
combined values of two independent experiments. A two-sample Kolmogorov–Smirnov test was used to compare paired distributions of Kv1.3
currents.
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Western blotting, immunoprecipitation and
autoradiogram
Western blots were analyzed with the following antibodies: p-Tyr,
Lck, Zap70, LAT, AKT, ERK 1/2, CD122 and GAPDH from Santa
Cruz; from Cell Signaling p-Src; Zap70 and p-Zap70; STAT5 and
p-STAT5; p-LAT; p-AKT; p-ERK 1/2. Kv1.3 antibody (Alomone
labs). Lck antibody-conjugated agarose (Santa Cruz) was used to
immunoprecipitate cell lysates. Details of Lck immunoprecipita-
tion and western immunoblottings were described elsewhere
[21]. Densitometric analysis with the ImageQuant v.5.1 software
(Molecular Dynamics) was used to quantify the intensity of
labeling. Pixel densities for each band were normalized within the
same experiment and autoradiography exposure.
Electrophysiology
We used the automated IonWorks HT high-throughput patch-
clamping system (Essen Instruments, Ann Arbor, MI, USA) as a
screening platform to determine Kv1.3 current profiles in
different T-cell subsets and culture conditions. It is worth noting
that the IonWorks HT device cannot screen for cell capacitances,
therefore we cannot estimate frequencies of the current density
[22]. Details on data protocols, conditions, processing algorithms
and validation of this methodology are described elsewhere [5].
Statistical analysis
The Kruskal–Wallis ANOVA test was used to determine differ-
ences in peak currents among multiple groups. Statistical
comparisons of current distributions between two samples were
performed using the Kolmogorov–Smirnov test. Differences were
considered significant when po0.01.
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